Curaleaf Holdings (CURLF) Acquisitions (2021 - 2022)
Curaleaf Holdings (CURLF) posted quarterly Acquisitions of $92.6 million for Q4 2022, down 67.68% year-over-year from $286.5 million in Q4 2021, and up 1582.17% quarter-over-quarter from $5.5 million in Q3 2022.
Curaleaf Holdings (CURLF) Acquisitions (2021 - 2022) Analysis & Trends
Curaleaf Holdings' Acquisitions history runs 2 years deep, the most recent figure standing at $92.6 million for Q4 2022.
- In Q4 2022, Acquisitions fell 67.68% year-over-year to $92.6 million; the TTM figure through Dec 2022 stood at $119.2 million (changed N/A YoY), while the FY2025 annual figure was $542000.0, down 88.47% from the prior year.
- Acquisitions for Q4 2022 stood at $92.6 million, up from $5.5 million in the prior quarter.
- The five-year high for Acquisitions was $286.4 million in Q4 2021, with the low at -$12000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Curaleaf Holdings | 2.51 Bn | 2.42 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 92.57 Mn |
| Sep 30, 2022 | 5.50 Mn |
| Jun 30, 2022 | 2.27 Mn |
| Mar 31, 2022 | 18.87 Mn |
| Dec 31, 2021 | 286.45 Mn |
| Sep 30, 2021 | -12,000.00 |